Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's DiseaseSamantha Budd Haeberlein, Alfred Sandrock, Cath Mummery et al.|The Journal of Prevention of Alzheimer s Disease|2022Cited by 1.3k